journal
MENU ▼
Read by QxMD icon Read
search

European Urology

journal
https://www.readbyqxmd.com/read/28716370/a-systematic-review-and-framework-for-the-use-of-hormone-therapy-with-salvage-radiation-therapy-for-recurrent-prostate-cancer
#1
REVIEW
Daniel E Spratt, Robert T Dess, Zachary S Zumsteg, Daniel W Lin, Phuoc T Tran, Todd M Morgan, Emmanuel S Antonarakis, Paul L Nguyen, Charles J Ryan, Howard M Sandler, Matthew R Cooperberg, Edwin Posadas, Felix Y Feng
CONTEXT: Salvage radiotherapy (SRT) is a standard of care for men who recur postprostatectomy, and recent randomized trials have assessed the benefit and toxicity of adding hormone therapy (HT) to SRT with differing results. OBJECTIVE: To perform a systematic review of randomized phase III trials of the use of SRT ± HT and generate a framework for the use of HT with SRT. EVIDENCE ACQUISITION: Systematic literature searches were conducted on February 15, 2017 in three databases (MEDLINE [via PubMed], EMBASE, and ClinicalTrials...
July 14, 2017: European Urology
https://www.readbyqxmd.com/read/28716369/re-philipp-mandel-felix-preisser-markus-graefen-et-al-high-chance-of-late-recovery-of-urinary-and-erectile-function-beyond-12-months-after-radical-prostatectomy-eur-urol-2017-71-848-50-late-recovery-of-erectile-function-after-radical-prostatectomy-should-we
#2
LETTER
https://www.readbyqxmd.com/read/28712858/reply-to-paolo-capogrosso-francesco-montorsi-and-andrea-salonia-s-letter-to-the-editor-re-philipp-mandel-felix-preisser-markus-graefen-et-al-high-chance-of-late-recovery-of-urinary-and-erectile-function-beyond-12-months-after-radical-prostatectomy-eur-urol
#3
LETTER
https://www.readbyqxmd.com/read/28712857/reply-from-authors-re-mikkel-fode-jens-s%C3%A3-nksen-towards-a-greater-understanding-of-underactive-bladder-eur-urol-in-press-https-doi-org-10-1016-j-eururo-2017-04-017
#4
EDITORIAL
Alan D Uren, Nikki Cotterill, Christopher Harding, Christopher Hillary, Christopher Chapple, Monique Klaver, Dominique Bongaerts, Zalmai Hakimi, Paul Abrams
No abstract text is available yet for this article.
July 13, 2017: European Urology
https://www.readbyqxmd.com/read/28711383/gonadotropin-releasing-hormone-agonists-orchiectomy-and-risk-of-cardiovascular-disease-semi-ecologic-nationwide-population-based-study
#5
Frederik Birkebæk Thomsen, Fredrik Sandin, Hans Garmo, Ingela Franck Lissbrant, Göran Ahlgren, Mieke Van Hemelrijck, Jan Adolfsson, David Robinson, Pär Stattin
BACKGROUND: In observational studies, men with prostate cancer treated with gonadotropin-releasing hormone (GnRH) agonists had a higher risk of cardiovascular disease (CVD) compared to men who had undergone orchiectomy. However, selection bias may have influenced the difference in risk. OBJECTIVE: To investigate the association of type of androgen deprivation therapy (ADT) with risk of CVD while minimising selection bias. DESIGN, SETTING, AND PARTICIPANTS: Semi-ecologic study of 6556 men who received GnRH agonists and 3330 men who underwent orchiectomy as primary treatment during 1992-1999 in the Prostate Cancer Database Sweden 3...
July 12, 2017: European Urology
https://www.readbyqxmd.com/read/28711382/recreational-physical-activity-in-relation-to-prostate-cancer-specific-mortality-among-men-with-nonmetastatic-prostate-cancer
#6
Ying Wang, Eric J Jacobs, Susan M Gapstur, Maret L Maliniak, Ted Gansler, Marjorie L McCullough, Victoria L Stevens, Alpa V Patel
BACKGROUND: Large prospective cohort studies need to confirm the associations between recreational physical activity (PA), including the most common type-walking, and prostate cancer-specific mortality (PCSM) among prostate cancer patients. OBJECTIVE: To investigate the associations of recreational PA, reported before and after diagnosis, with PCSM, overall and by tumor risk category. DESIGN, SETTING, AND PARTICIPANTS: In a prospective cohort study conducted in the USA, men diagnosed with nonmetastatic prostate cancer between 1992/1993 and June 2011 were followed for mortality until 2012...
July 12, 2017: European Urology
https://www.readbyqxmd.com/read/28709729/reply-to-jae-heon-kim-bora-lee-and-benjamin-i-chung-s-letter-to-the-editor-re-philipp-mandel-felix-preisser-markus-graefen-et-al-high-chance-of-late-recovery-of-urinary-and-erectile-function-beyond-12-months-after-radical-prostatectomy-eur-urol-2017-71-848
#7
LETTER
https://www.readbyqxmd.com/read/28709728/re-philipp-mandel-felix-preisser-markus-graefen-et-al-high-chance-of-late-recovery-of-urinary-and-erectile-function-beyond-12-months-after-radical-prostatectomy-eur-urol-2017-71-848-50
#8
LETTER
https://www.readbyqxmd.com/read/28705540/three-year-safety-of-radium-223-dichloride-in-patients-with-castration-resistant-prostate-cancer-and-symptomatic-bone-metastases-from-phase-3-randomized-alpharadin-in-symptomatic-prostate-cancer-trial
#9
Christopher C Parker, Robert E Coleman, Oliver Sartor, Nicholas J Vogelzang, David Bottomley, Daniel Heinrich, Svein I Helle, Joe M O'Sullivan, Sophie D Fosså, Aleš Chodacki, Paweł Wiechno, John Logue, Mihalj Seke, Anders Widmark, Dag Clement Johannessen, Peter Hoskin, Nicholas D James, Arne Solberg, Isabel Syndikus, Jan Kliment, Steffen Wedel, Sibylle Boehmer, Marcos Dall'Oglio, Lars Franzén, Øyvind S Bruland, Oana Petrenciuc, Karin Staudacher, Rui Li, Sten Nilsson
BACKGROUND: In Alpharadin in Symptomatic Prostate Cancer (ALSYMPCA) trial, radium-223 versus placebo prolonged overall survival with favorable safety in castration-resistant prostate cancer patients with symptomatic bone metastases. Long-term radium-223 monitoring underlies a comprehensive safety and risk/benefit assessment. OBJECTIVE: To report updated ALSYMPCA safety, including long-term safety up to 3 yr after the first injection. DESIGN, SETTING, AND PARTICIPANTS: Safety analyses from phase 3 randomized ALSYMPCA trial included patients receiving ≥1 study-drug injection (600 radium-223 and 301 placebo)...
July 10, 2017: European Urology
https://www.readbyqxmd.com/read/28705539/value-of-an-immediate-intravesical-instillation-of-mitomycin-c-in-patients-with-non-muscle-invasive-bladder-cancer-a-prospective-multicentre-randomised-study-in-2243-patients
#10
Judith Bosschieter, Jakko A Nieuwenhuijzen, Tessa van Ginkel, André N Vis, Birgit Witte, Don Newling, Goedele M A Beckers, R Jeroen A van Moorselaar
BACKGROUND: The efficacy of an immediate single chemotherapy instillation after transurethral resection of a bladder tumour (TURBT) in patients with non-muscle-invasive bladder cancer (NMIBC) remains a topic of debate. Evidence is even more scarce when an immediate instillation is followed by adjuvant instillations. OBJECTIVE: To compare the effect of a mitomycin C (MMC) instillation within 24h to an instillation 2 wk after TURBT in patients with NMIBC with or without adjuvant instillations...
July 10, 2017: European Urology
https://www.readbyqxmd.com/read/28693939/reply-to-julie-steinestel-christof-bernemann-andres-j-schrader-and-jochen-k-lennerz-s-letter-to-the-editor-re-emmanuel-s-antonarakis-changxue-lu-brandon-luber-et-al-clinical-significance-of-androgen-receptor-splice-variant-7-mrna-detection-in-circulating-tumor
#11
LETTER
https://www.readbyqxmd.com/read/28693938/will-retzius-sparing-prostatectomy-be-the-future-of-prostate-cancer-surgery
#12
EDITORIAL
Antonio Galfano, Silvia Secco, Aldo Massimo Bocciardi
No abstract text is available yet for this article.
July 7, 2017: European Urology
https://www.readbyqxmd.com/read/28689900/re-sungmin-woo-chong-hyun-suh-sang-youn-kim-jeong-yeon-cho-seung-hyup-kim-diagnostic-performance-of-magnetic-resonance-imaging-for-the-detection-of-bone-metastasis-in-prostate-cancer-a-systematic-review-and-meta-analysis-eur-urol-in-press-http-dx-doi-org-10
#13
LETTER
https://www.readbyqxmd.com/read/28689899/maximising-recruitment-to-randomised-controlled-trials-the-role-of-qualitative-research-to-inform-recruitment-challenges
#14
EDITORIAL
Penny Wright
No abstract text is available yet for this article.
July 6, 2017: European Urology
https://www.readbyqxmd.com/read/28688614/re-emmanuel-s-antonarakis-changxue-lu-brandon-luber-et-al-clinical-significance-of-androgen-receptor-splice-variant-7-mrna-detection-in-circulating-tumor-cells-of-men-with-metastatic-castration-resistant-prostate-cancer-treated-with-first-and-second-line-abiraterone
#15
LETTER
https://www.readbyqxmd.com/read/28688613/brachytherapy-boost-utilization-and-survival-in-unfavorable-risk-prostate-cancer
#16
Skyler B Johnson, Nataniel H Lester-Coll, Jacqueline R Kelly, Benjamin H Kann, James B Yu, Sameer K Nath
BACKGROUND: There are limited comparative survival data for prostate cancer (PCa) patients managed with a low-dose rate brachytherapy (LDR-B) boost and dose-escalated external-beam radiotherapy (DE-EBRT) alone. OBJECTIVE: To compare overall survival (OS) for men with unfavorable PCa between LDR-B and DE-EBRT groups. DESIGN, SETTING, AND PARTICIPANTS: Using the National Cancer Data Base, we identified men with unfavorable PCa treated between 2004 and 2012 with androgen suppression (AS) and either EBRT followed by LDR-B or DE-EBRT (75...
July 5, 2017: European Urology
https://www.readbyqxmd.com/read/28688612/comprehensive-molecular-characterization-of-urothelial-bladder-carcinoma-a-step-closer-to-clinical-translation
#17
EDITORIAL
Cyrill A Rentsch, David C Müller, Christian Ruiz, Lukas Bubendorf
No abstract text is available yet for this article.
July 5, 2017: European Urology
https://www.readbyqxmd.com/read/28688611/reply-to-jae-heon-kim-bora-lee-and-benjamin-i-chung-s-letter-to-the-editor-re-sungmin-woo-chong-hyun-suh-sang-youn-kim-jeong-yeon-cho-seung-hyup-kim-diagnostic-performance-of-magnetic-resonance-imaging-for-the-detection-of-bone-metastasis-in-prostate-cancer
#18
LETTER
https://www.readbyqxmd.com/read/28687145/re-eric-a-klein-arnon-chait-jason-m-hafron-et-al-the-single-parameter-structure-based-isopsa-assay-demonstrates-improved-diagnostic-accuracy-for-detection-of-any-prostate-cancer-and-high-grade-prostate-cancer-compared-to-a-concentration-based-assay-of-total
#19
LETTER
https://www.readbyqxmd.com/read/28687144/re-the-prostate-health-index-adds-predictive-value-to-multi-parametric-mri-in-detecting-significant-prostate-cancers-in-a-repeat-biopsy-population
#20
journal
journal
20110
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"